Orthopedic Bone Cement and Casting Materials Market Size – By Product (Bone Cement {Polymethylmethacrylate (PMMA), Acrylic}, Casting Material {Plaster of Paris, Fiberglass}, By Application (Fracture Management, Joint Replacement, Orthopedic Trauma), By Consumer (Adult, Pediatric), By End-use, & Global Forecast, 2023 – 2032

Orthopedic Bone Cement and Casting Materials Market Size – By Product (Bone Cement {Polymethylmethacrylate (PMMA), Acrylic}, Casting Material {Plaster of Paris, Fiberglass}, By Application (Fracture Management, Joint Replacement, Orthopedic Trauma), By Consumer (Adult, Pediatric), By End-use, & Global Forecast, 2023 – 2032

Orthopedic Bone Cement and Casting Materials Industry Analysis

Orthopedic Bone Cement and Casting Materials Market size was valued at around USD 2.9 billion in 2022 and is estimated to reach over USD 6.2 billion by 2032 due to rising prevalence of orthopedic disorders & injuries, advancements in casting materials & techniques, and a growing demand for minimally invasive procedures. This trend has led to the development of alternative casting techniques such as removable or adjustable casts & braces, that allow patients to maintain mobility & engage in rehabilitation exercises.
 

Furthermore, with the rising number of orthopedic surgeries & fractures, there is a growing demand for orthopedic casting supplies, including casting tapes, bandages, splints, and padding materials among others. This has created opportunities for manufacturers & suppliers of these orthopedic devices. Overall, the industry is expected to experience steady gains in the coming years, driven by growing demand for minimally invasive procedures, increasing usage of orthopedic support systems, etc.
 

Orthopedic bone cement and casting materials are specialized medical products used in the field of orthopedics to treat fractures, bone injuries, and other skeletal conditions. Orthopedic bone cement is a substance commonly used in joint replacement surgeries, such as hip and knee replacements. It is a biocompatible material that fills the gap between the artificial joint and the natural bone. Casting materials are used in the process of immobilizing and supporting fractured bones, allowing them to heal properly.

However, adverse reactions & complications associated with the orthopedic bone cement & casting materials may obstruct the segment revenue. Some individuals may develop an allergic reaction to the materials used in bone cement. In severe cases, it may lead to difficulty breathing or anaphylaxis, a life-threatening allergic reaction. The casting materials can cause skin irritation & discomfort, particularly if the cast is improperly fitted or not adequately padded. Prolonged pressure on the skin can lead to pressure sores or ulcers, especially in individuals with limited mobility or sensation.
 

COVID-19 Impact

The COVID-19 pandemic has had a negative impact on the orthopedic bone cement and casting materials market. There was a temporary decline in demand for orthopedic procedures, including bone cement and casting materials. This is attributable to the pandemic's widespread impact on healthcare systems and restrictions on elective surgeries. Many hospitals and healthcare facilities focused their resources on COVID-19 treatment, leading to a decrease in elective orthopedic surgeries. Manufacturing facilities faced temporary closures or reduced production capacity, leading to supply shortages and delays in the availability of orthopedic bone cement and casting materials. To minimize in-person visits and reduce the risk of exposure, telemedicine emerged as a preferred mode of consultation for non-urgent orthopedic cases.
 

However, in 2021, the technological advancements and incorporation of advanced imaging techniques have augmented target disease diagnosis and treatment compliance and promoted the acceptance of products. In addition, some of the procedures if not performed on time may lead to the death of patients.
 

Orthopedic Bone Cement and Casting Materials Market Trends

Technological advancements in orthopedic bone cement & casting materials aimed at improving patient outcomes and simplifying the casting process. Advanced 3D printing technology is allowing the creation of customized casts. Using patient-specific data from medical imaging, 3D-printed casts can be designed to provide a better fit, support, and immobilization. These casts are commonly lightweight, breathable, and waterproof, enhancing patient comfort and hygiene. Injectable bone cement has emerged to assist in the treatment of fractures or bone defects. These cements are typically made of a biocompatible polymer mixed with bioactive substances, such as calcium phosphate or hydroxyapatite, to enhance bone regeneration. Researchers are investing on the integration of smart technologies into casting materials.
 

For instance, sensors can be embedded within casts to monitor factors comprising pressure, temperature, and moisture levels. This will allow real-time monitoring of the healing process, early detection of complications, and more targeted treatment approaches.
 

Orthopedic Bone Cement and Casting Materials Product Segmentation

Based on product, the orthopedic bone cement and casting materials market is segmented as bone cement and casting materials. The bone cement segment was valued at over USD 1.5 billion in 2022. This dominant market share is attributable to the several advantages associated with the orthopedic bone cement in orthopedic surgery to fix & stabilize implants, particularly in joint replacement procedures. Bone cement is providing a reliable and strong bond between the prosthesis and the surrounding bone, ensuring stable implant fixation. This stability is observed as critical for the long-term success of joint reconstructions or replacements, as it allows patients to regain function and mobility. These products are enabling minimally invasive surgical procedures as it can be injected through narrow incisions.
 

Moreover, advancements in orthopedic bone cement have focused on improving its properties and performance. Some notable advancements include enhanced biocompatibility, antibiotic-loaded cement, and bioactive additives among others. Novel bone cement formulations have been developed with enhanced mechanical strength. These formulations provide increased durability and resistance to wear, ensuring long-lasting stability of joint replacements.
 

Orthopedic Bone Cement and Casting Materials Application Segmentation

Based on application, the orthopedic bone cement and casting materials market is segmented as fracture management, joint replacement, orthopedic trauma, and others. The joint replacement segment exceeded USD 1.1 billion in 2022. This high segmental revenue share is owing to the orthopedic bone cement and casting materials are playing an essential role in joint replacement procedures. Antibiotics loaded bone cement is allowing the localized delivery of antimicrobial agents. This helps to reduce the risk of infection at the surgical site, that  is a significant concern in joint replacement procedures. Infection after joint replacement surgery can lead to the need for revision surgery, that is a more complex and risky procedure.
 

The use of antibiotic-loaded bone cement has been shown to reduce the incidence of infection and subsequent revision surgeries, leading to improved patient outcomes. Furthermore, personalized casting is offering better support and immobilization, that is crucial for successful recovery after joint replacement. Novel non-invasive casting materials can be applied externally, making them a less complex and safer option for postoperative care. Casting materials can also be used in a variety of joint replacement procedures and orthopedic conditions. They are not limited to specific joints and can be adapted to different surgical techniques and patient needs.
 

Orthopedic Bone Cement and Casting Materials Consumer Segmentation

Based on consumer, the orthopedic bone cement and casting materials market is segmented as adult and pediatric. The adult segment was valued at around USD 2.2 billion in 2022. This significant expansion is pertaining to the rising prevalence of orthopedic disorders and other chronic diseases in adults and the growing geriatric population base globally.
 

As per the National Institute of Health, in 2020, around 654 million individuals aged 40 years and above were suffering with knee osteoarthritis worldwide. Similarly, adults may require orthopedic surgeries for conditions such as joint replacements, fracture repairs, or spinal surgeries. Orthopedic bone cement is commonly utilized during these procedures to fix implants securely in place or fill bone voids. Orthopedic casting materials are also used to immobilize the injured area, providing stability and facilitating the healing process.
 

Orthopedic Bone Cement and Casting Materials End-use Segmentation

Based on end-use, the orthopedic bone cement and casting materials market is segmented as hospitals, ambulatory surgical centers, and orthopedic clinics. The hospitals segment dominated the market with 55% revenue share in 2022. High adoption of advanced procedures providing improved outcomes will drive the patient preference for hospitals. Increasing admissions with various sports injuries & trauma along with the availability of trained professionals impel the demand for sports medicine products comprising fracture & ligament repair products in these facilities.
 

As per the Johns Hopkins University data, in the U.S., over 3.5 million sports injuries occur every year in the U.S. Additionally, hospitals provide continuous monitoring after procedures, design exercise to restore strength, work closely with patients, and offer physical therapies. Additionally, the surging patient inflow has further increased the product adoption rate.
 

Orthopedic Bone Cement and Casting Materials Regional Analysis

North America orthopedic bone cement and casting materials market is anticipated to reach around USD 2.8 billion by 2032. One of the primary drivers is the increasing prevalence of orthopedic disorders such as osteoporosis, arthritis, and fractures. According to the CDC data, around 60 million people in the U.S. have doctor diagnosed arthritis. These conditions often require medical intervention, including the use of bone cement and casting materials for fracture fixation, joint replacements, and other orthopedic procedures. As the elderly population increases, the incidence of age-related orthopedic conditions also rises, leading to a higher demand for orthopedic procedures and associated products.
 

Orthopedic Bone Cement and Casting Materials Industry Leaders

Some of the major market players operating in the orthopedic bone cement and casting materials market are 3M Health Care, Arthrex, Biomet, BSN medical GmbH, DePuy Synthes (Johnson & Johnson), DJO Global, and Exactech among others.
 

Orthopedic Bone Cement and Casting Materials Industry News

• In December 2021, DePuy Synthes announced the acquisition of OrthoSpin, Ltd, an Israeli company engaged in manufacturing and production of orthopedic devices and solutions. This acquisition helped the company to enhance their product portfolio in osteoarthritis and increase the available treatment options for a wide customer base thereby generating robust business revenue.
   
• In November 2020, Stryker announced the acquisition of Wright Medical Group N.V. a medical device company engaged in extremities and biologics. This acquisition helped the company to enhance their market presence in trauma and extremities thereby diversifying their product portfolio and generating a robust business revenue.

Orthopedic bone cement and casting materials market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD (million) from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Product, 2018 - 2032 (USD Million)

• Bone Cement  
  • Polymethylmethacrylate (PMMA)
  • Acrylic
  • Others
• Casting Material
  • Plaster of Paris
  • Fiberglass
  • Others

By Application, 2018 - 2032 (USD Million)

• Fracture Management
• Joint Replacement
• Orthopedic Trauma
• Others

By Consumer, 2018 - 2032 (USD Million)

• Adult
• Pediatric

By End-use, 2018 - 2032 (USD Million)

• Hospitals
• Ambulatory surgical centers
• Orthopedic clinics

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Switzerland
  • The Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Iran
  • Turkey